Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > MarketRealist on CRDL

<< Previous

Bullboard Posts

Next >>

Comment by NewFanCBDon Sep 15, 2021 10:56pm

275 Views

Post# 33866995

RE:RE:MarketRealist on CRDL

Yes I like the movement upward after the consolidation here from $4.58 Canadian. This will continue to move up as COVID cases increase. Lots of moving parts that's for sure. May run higher, quite higher then $6.00. Go crdl Go.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China